TMO Financial Facts
Total revenues: 4.49BCost of product revenues: 2.02B
See Full Income Statement
Other Assets: 1.1B
Total Assets: 48.01B
See Full Balance Sheet
Thermo Fisher Scientific, Inc. (TMO) Earnings
|
Expand Research on TMO
Next EPS Date | 7/24/24 *Est. | EPS Growth Rate | +1.6% *Last Qtr. |
---|---|---|---|
Average EPS % Beat Rate | +1.2% | Revenue Growth Rate | -3.5% *Last Qtr. |
Average % Move 1-Wk after EPS | -2.3% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
10/27/10 | Q310 | $0.90 | $0.83 | +$0.07 | N/A | N/A | N/A | Details | |||
4/27/11 | Q111 | $0.92 | $0.88 | +$0.04 | $2.72B | $2.65B | = | Details | |||
7/27/11 | Q211 | $0.99 | $0.98 | +$0.01 | $2.9B | $2.84B | = | Details | |||
10/26/11 | Q311 | $1.07 | $1.07 | $0.00 | $2.97B | $3B | = | Details | |||
4/25/12 | Q112 | $1.17 | $1.10 | +$0.07 | $3.1B | $2.97B | Details | ||||
2/1/12 | Q411 | $1.18 | $1.15 | +$0.03 | $3.13B | $3.08B | Details | ||||
10/24/12 | Q312 | $1.19 | $1.16 | +$0.03 | $3.09B | $2.99B | Details | ||||
7/25/12 | Q212 | $1.22 | $1.16 | +$0.06 | $3.11B | $3.05B | Details |